Opportunity ID: 249447

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: RFA-CA-14-003
Funding Opportunity Title:: Early-Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Education
Category Explanation::
Expected Number of Awards:: 22
Assistance Listings Number(s):: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 1
Posted Date:: Dec 20, 2013
Last Updated Date::
Original Closing Date for Applications:: Sep 18, 2014
Current Closing Date for Applications:: Sep 18, 2014
Archive Date:: Oct 19, 2014
Estimated Total Program Funding:: $ 5,000,000
Award Ceiling:: $200,000
Award Floor:: $

Eligibility

Eligible Applicants:: Native American tribal governments (Federally recognized)
Additional Information on Eligibility:: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name:: National Institutes of Health
Description:: This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the inception and development of early stage, highly innovative, technologies for the molecular or cellular analysis of cancer. Emerging technologies with significant transformative potential that have not yet been explored in a cancer-relevant use may also be considered. An emerging technology is defined (for the purpose of this FOA) as one that has passed the initial developmental stage, but has not yet been evaluated within the context of cancer-relevant use intended in the application and requires significant modification for the proposed application to establish feasibility. The emphasis of this FOA is on molecular analysis technologies with a high degree of technical innovation with the potential to significantly affect and transform investigations exploring the molecular and cellular bases of cancer. If successful, these technologies would accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be based on molecular and/or cellular characterizations of cancer.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Packages

Assistance Listings Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions Who Can Apply:
FORMS-C Forms-C PKG00191264 Jan 20, 2014 Sep 18, 2014 View eRA Commons Help Desk Organization Applicants